The paediatric traveller by Korzeniewski, Krzysztof
www.intmarhealth.pl
Int Marit Health 
2018; 69, 1: 70–74 
DOI: 10.5603/IMH.2018.0011 
www.intmarhealth.pl 
Copyright © 2018 PSMTTM 
ISSN 1641–9251
REV IEW ART ICLE
70
Krzysztof Korzeniewski, MD, PhD, Professor at Military Institute of Medicine, Department of Epidemiology and Tropical Medicine, ul. Grudzińskiego 4, 81–103 Gdynia,  
Poland, e-mail: kkorzeniewski@wim.mil.pl
The paediatric traveller
Krzysztof Korzeniewski
Department of Epidemiology and Tropical Medicine, Military Institute of Medicine, Warsaw, Poland
AbsTrAcT
International travel with children, which is the opportunity for the family to see the world together, has 
become commonplace. If you are travelling with children the journey needs to be carefully planned, espe-
cially in cases of visiting a region with harsh environment or poor sanitation. It is particularly important in 
terms of thermoregulation (hot climate) and the immune system (protection against pathogens causing 
infectious and invasive diseases) as these are not fully developed in small children. In addition, it is im-
portant to maintain appropriate safety and security measures in the destination area (e.g. using child 
car seats during drive, supervising children during recreational activities in water and on land, avoiding 
contact with undomesticated animals). Moreover, it is essential to prepare a travel health kit containing 
drugs appropriate for young travellers — matched for their age and body weight, and to purchase personal 
prevention products for everyday use (sunscreen with a high sun protection factor, insect repellents, etc.).  
(Int Marit Health 2018; 69, 1: 70–74)
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INTrODUcTION
As regards children, travel medicine currently focuses 
on four major areas: travel comfort and safety, vaccinations, 
prevention of vector-borne diseases and prevention and 
treatment of diarrheal illnesses [1]. The types of prevention 
measures to be taken before and throughout travel depend 
on a variety of factors, such as age, the general condi-
tion of a child (pre-travel health assessment is necessary, 
a child must be examined for allergies, dental caries, chronic 
infectious and non-infectious diseases), destination and 
time of travel. The benefits of travelling with children are 
quite obvious (spending time together, fun and play, learning 
values); however, travellers must be aware of certain health 
risks which may emerge, especially during overseas travel. 
The decision whether to take a child on a journey is up to 
their parents or guardians. Parents, however, need to be 
rational and use their common sense whenever they plan 
their travel activities. It is their decision whether to take their 
child on a trip to the jungle, a desert or in high mountains, 
or, if it is better to spend their holiday by a hotel swimming 
pool or on the beach. In general, travelling with children is 
becoming increasingly popular. Nowadays, children account 
for one in ten international travellers. Adult travellers take 
their children practically everywhere, unfortunately they 
tend to forget that in the wilderness of Africa, Asia or South 
America, where the nearest health care provider is tens or 
hundreds kilometres away, a travel health kit is not enough 
to save their child’s life in an emergency. Inadequate risk 
assessment, i.e. evaluating the risk from the perspective 
of an adult, and disregard for the special requirements of 
paediatric travellers, whose thermoregulatory and immune 
systems are not yet fully developed (an increased risk of 
heat injuries and infections), is not only a lack of knowledge 
but also extreme irresponsibility [2–4]. 
TrAVELLING bY PLANE
Generally, air travel is considered safe for small children 
and infants. The barometric pressure as well as the oxygen 
concentration inside passenger aircrafts are reduced — the 
former corresponding to the altitude of 1800–2400 m 
above sea level, and the latter being the equivalent of 15% 
oxygen at sea level. Reduced oxygen content on a passenger 
plane is not problematic for healthy travellers, but it can 
pose a health hazard for children with chronic respiratory 
tract infections. Those children may require the adminis-
tration of supplemental oxygen when travelling by air [5].
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TrAVELLING bY cAr
Children should always travel in a car seat with their 
seatbelts fastened. Travellers to developing countries need 
to keep in mind that traffic laws are rarely obeyed by the 
locals. Therefore, it is extremely important for a driver to ad-
just their speed to the road conditions in a given destination 
and the nonchalance of local drivers; it will help ensure the 
safety for themselves and their passengers. In general, more 
international travellers die in traffic accidents than from 
infectious or invasive diseases, the statistics also apply to 
children. All travellers should be particularly careful when 
crossing the road because in some countries that fact that 
a pedestrian is on a zebra crossing does not necessarily 
mean they have priority. All over the world, there are coun-
tries where the car takes priority over the pedestrian and 
where drivers would use the horn or wave their hands to 
express their intentions; all travellers should remember 
about this, especially when travelling with children [6, 7].   
MOTION sIcKNEss
Motion sickness is a common condition associated with 
car, air or sea travel which is caused by intense motion. It 
occurs when there is a mismatch of information between 
the auditory and the visual system. While the visual system 
registers movement and sends appropriate signal to the 
brain, the vestibular system, which is responsible for the 
sense of balance, does not register motion. This leads to 
a mismatch of information between the two systems result-
ing in motion sickness with symptoms including nausea, 
vomiting, dizziness, sweating, excessive salivation. Motion 
sickness most often affects girls aged 2–12. Symptoms usu-
ally disappear as soon as motion (travel) stops. To prevent 
motion sickness, a child should be seated in a place where 
they will experience the least movement, e.g. the front seat 
in a car; the middle of a boat or a plane, best by a window, 
near the wing and on the right side of a plane. Before travel, 
children should not have heavy meals, sweets or fizzy drinks. 
In Poland, the most popular over-the-counter medication 
to prevent motion sickness is dimenhydrinate (Aviomarin 
syrup 12.5 mg/5 mL; tab. 50 mg) which should be taken 
30 min before travel at a dose of 1.25 mg/kg body mass, max. 
50 mg in a single dose (the onset of action after application 
is 20–30 min and the duration of action is usually 4–6 h). 
The drug is contraindicated in children under 2 years of age 
and those with epilepsy. Another popular drug to prevent 
motion sickness in children is promethazine (Diphergan 
syrup 5 mg/5 mL). It can be used in children over the age 
of one year [6, 8].
sKIN PrOTEcTION
When travelling to destinations with intense sunlight, it 
is very important to take special precautions against sun-
burns (sunscreen) and a sun stroke (hats). This particularly 
applies to children as their skin is much more sensitive and 
therefore more susceptible to sunburns. Firstly, you need to 
find out what skin type you child has. People with fair com-
plexion (skin type I) are much more susceptible to sunburns 
than those with dark skin (skin type IV). When choosing 
a sunscreen, you should pay attention to the sun protection 
factor (SPF), which is defined as the UV energy required 
to produce a minimal erythema dose (MED) on protected 
skin, divided by the UV energy required to produce a MED 
on unprotected skin, or a measure of how quickly your skin 
will become sunburnt with or without protection. SPF 15 
blocks approximately 93%, and the SPF 30 blocks 96% of 
harmful UV radiation. In children, it is recommended to use 
a sunscreen with an SPF of at least 30, 15–30 min before 
sun exposure. Sunscreen needs to be reapplied each time 
after you take a bath, go swimming or if you sweat heavily. 
Sunscreen should not be used in children under 6 months; 
instead infants need to be kept in the shade away from 
direct sunlight [6, 9].
VAccINATIONs 
In case of children, the vaccines administered before 
travel are usually a complement to national immunisation 
programmes [10, 11]. In Poland, the compulsory immuni-
sation schedule for children includes vaccinations against 
the following diseases: tuberculosis, diphtheria, tetanus, 
pertussis, polio, hepatitis B, measles, mumps, rubella and 
Haemophilus influenzae type b invasive infection. Table 1 
presents all mandatory (against yellow fever; invasive me-
ningococcal disease for travellers to Saudi Arabia) and 
recommended vaccinations to be taken before travel [6]. 
Particular attention needs to be given to children with 
special health problems (children with allergies, diabetes, 
immunodeficiency disorders or those taking immunosup-
pressants) before they get vaccinated. In such cases, immu-
noprophylaxis needs to be individualized to avoid possible 
adverse events [12].  
PrEVENTION OF VEcTOr-bOrNE DIsEAsEs
Before going abroad, especially to destinations where 
vector-borne diseases are endemic, travellers are recom-
mended to buy all the necessary items for personal protec-
tion, first and foremost, insect repellents. When travelling 
to destinations where there are a lot of flying insects (e.g. 
mosquitoes, flies) always check if the air-conditioning in 
your hotel room is working properly (if it is available). Also, 
make sure if insect screens are tightly fitting the windows 
and ventilation grills and if a mosquito net around you bed 
is not damaged (spray it with Permethrin for additional pro-
tection). Travellers must also keep in mind that they can get 
bitten by other insects as well, e.g. ticks that are prevalent 
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Table 1. Recommendations for the use of vaccinations in children. Source: [6]
Disease Dosage  boosters 
Cholera Children aged 2–6 years: 3 doses at the intervals of 1–6 weeks;  
children over 6 years of age: 2 doses at the intervals of 1–6 weeks
Immunity persists for 6 months (chil-
dren aged 2–6 years) and for up to 
2 years (children over 6 years)
Hepatitis A 2 doses: 0, 6–12 month (Havrix) the first dose given to children over 2 years 
of age; 0, 6–36 months (Avaxim) the first dose given to children at 1 year of 
age; accelerated vaccination course against hepatitis A and B: day 0, 7, 21 
and a single booster dose after 12 months
Not required according to WHO  
recommendations
Typhoid fever (poly-
saccharide vaccine) 
A single dose for children over the age of 2 years Every 2–3 years
Invasive meningo-
coccal disease  
A single dose for children over 2 months (Nimenrix);  
for children over 2 years (Menveo)
Not required according to the  
manufacturer 
Rabies Pre-exposure vaccination — days: 0, 7, 28 (WHO recommendations:  
days 0, 7, 21 or 28); a complementary dose: after 12 months
Post-exposure vaccination for previously immunised children: 2 doses  
— on the day of being bitten and 3 days after; no age limitations 
Every 5 years
Yellow fever A single dose for children over 9 months Not required according to WHO  
recommendations
Tick-borne  
encephalitis
3 doses: 0, 1–3 month, 9–12 month; the first dose for children  
over the age of 1 year
Every 3 years
WHO — World Health Organisation
in deciduous forests, bushes, pastures with tall grass, or 
fleas and lice in areas with poor sanitation. To prevent insect 
bites travellers are recommended to cover as much of their 
body as possible (wearing long-sleeved shirts or tops, long 
trousers). Although many flying insects are most active from 
dusk to dawn, there are insects which stay active during 
the day e.g. tsetse flies transmitting African trypanosomia-
sis. To make matters worse, tsetse flies are insensitive to 
most repellents. Stagnant water is the favourite breeding 
ground for a number of flying insects. Therefore travellers 
are recommended to avoid staying outdoors and close to 
standing water after dark, when infection vectors (including 
mosquitoes transmitting malaria) are the most active.
The most common and readily available repellents are 
those containing N,N-diethyl-meta-toluamide (DEET). The 
research has showed that they are safe for children provided 
that they are only applied onto skin and no more than sev-
eral times a day. Applying the repellent around the eyes can 
cause conjunctivitis, while inhaling or swallowing products 
containing DEET may produce symptoms indicating poison-
ing. Neurological disorders were reported in children using 
insect repellents more than 10 times during a day, especially 
if they were in a habit of licking the skin covered with the 
repellent. In general, products with a higher concentration 
of DEET will normally have a longer lasting effect, e.g. DEET 
concentration of 5–7% provides protection for 1–2 h after 
application, whereas a concentration of 24% will ensure 
a 5-h protection. The maximum concentration of DEET in 
products used on children should not exceed 30%. Still, 
even if you regularly use insect repellents, a child may get 
bitten by a mosquito or other insects. If the bite is itchy or 
inflamed you should give your child an antihistamine e.g. 
topically applied dimethindene (Fenistil) gel or orally admin-
istered loratadine (Claritine) or cetirizine (Zyrtec) syrup or 
tablets. This will not only quickly relieve symptoms but also 
prevent a secondary bacterial infection, which is likely to 
occur as children tend to scratch itchy spots, which might 
lead to the formation of oozing lesions and secondary im-
petiginisation [6, 12–14]. 
ANTIMALArIAL cHEMOPrOPHYLAXIs
Chloroquine, proguanil and mefloquine are recommend-
ed to breastfeeding mothers. Drug dosage regimen is based 
on a child’s body weight. The bitter taste of antimalarials can 
be masked with sweet-tasting food or drinks. Chloroquine 
and proguanil are safe for young children; however, their use 
is limited owing to the growing resistance of Plasmodium to 
these drugs. Mefloquine can be used in children with the 
body weight of more than 5 kg. Atovaquone/proguanil is 
recommended for children with the body weight of more than 
11 kg (in the USA, Canada, Belgium and France — for children 
weighing more than 5 kg). Doxycycline is contraindicated 
in children under the age of 8 years (Table 2) [6, 15, 16].
TrEATMENT OF MALArIA
P. vivax, P. ovale, P. malariae infections are usually 
treated with chloroquine, unless chloroquine-resistance has 
been confirmed. Severe malaria cases should be treated 
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Table 2. Drugs used for antimalarial chemoprophylaxis in children. Source: [6]
Drug Dosage Duration  
of chemoprophylaxis 
Note 
atovaquone/proguanil
paediatric tablet
62.5 mg/25 mg 
1 × day
5–11 kg bw: 31.25 mg/12.5 mg
11–20 kg bw: 62.5 mg/25 mg
21–30 kg bw: 125 mg/50 mg
31–40 kg bw: 187.5 mg/75 mg
> 40 kg bw: 250 mg/100 mg  
(adult tablet) 1× 1 tablet
1 day before travel,  
every day during travel,  
7 days after travel
Very rare gastrointestinal,  
dermatological adverse events
doxycycline 
tablet 100 mg
1 × day in children over 8 years of age
2 mg/kg bw (max 100 mg per day)
1 day before travel,  
every day during travel,  
28 days after travel
Gastrointestinal, dermatological,  
gynaecological adverse events
mefloquine 
tablet 250 mg
1 × week
< 10 kg: 5 mg/kg bw
10–19 kg: 1/4 tablet 
20–30 kg: 1/2 tablet
31–45 kg: 3/4 tablet
> 45 kg: 1 tablet   
1 week before travel,  
1 × week during travel,  
4 weeks after travel
Gastrointestinal, neuropsychiatric  
adverse events
chloroquine 
tablet 150 mg
1 × week
5 mg/kg body weight (max 300 mg)
1 week before travel,  
1 × week during travel,  
4 weeks after travel 
Gastrointestinal, dermatological  
adverse events; contraindicated  
in epilepsy and psoriasis
Table 3. Drugs used for the treatment of malaria in children. 
Source: [6]
Drug Dosage
artesunate 2.4 mg/kg bw IV or IM
0 h (1st dose), 12 h (2nd dose), 24 h (3rd dose),
next: once daily
artemether 3.2 mg/kg bw IM (1st dose)
next: 1.6 mg/kg bw once daily
quinine 20 mg/kg bw IV infusion or IM
in 3 split doses administered every 8 h (initial dose)
next: 10 mg/kg bw IM
in 3 split doses administered every 8 h
Note: in case of IV administration the dose  
cannot exceed 5 mg/kg bw per hour
artesunate  
+ clindamycin
2 mg/kg bw artesunate once daily for  
7 days + 10 mg/kg bw clindamycin twice  
daily for 7 days
chloroquine 25 mg/kg bw in 3 split doses per day 
(10 mg/kg, 10 mg/kg and 5 mg/kg) 
for 3 consecutive days (do not use in  
P. falciparum malaria)
with artesunate (intravenous or intramuscular administra-
tion) or with artemether or quinine if artesunate is unavail-
able. Parenteral therapy should be continued for at least 
24 h and next be followed by the oral artemisinin-based 
combination therapy, artesunate + clindamycin or quinine 
+ clindamycin (Table 3). Standby emergency treatment of 
malaria: artemether/lumefantrine (children with the body 
weight of more than 5 kg, limited clinical data), atovaquone/ 
/proguanil (children with the body weight of more than 
5 kg, limited clinical data), dihydroartemisinin/piperaquine 
(children with the body weight of more than 10 kg, limited 
clinical data) [6]. 
PrEVENTION OF FOOD- AND  
WATEr-bOrNE INFEcTIONs
Generally, the same principles of prevention apply to 
adults and children. However, there are several differences 
which need to be pointed out. If a child is breastfed, then it 
is crucial that the nursing mother has a healthy diet. If she 
avoids risk factors, her baby will be safe. This is extremely 
important, considering the fact that diarrheal diseases are 
more often seen in infants and toddlers (40%) than older 
children (9–22%). The highest prevalence of traveller’s diar-
rhoea is reported among children under the age of 2 years. 
In order to avoid the transmission of food and waterborne 
infections it is extremely important that children frequently 
wash their hands (always before eating), because they often 
tend to put their fingers in their mouth or bite their nails. In 
countries with poor sanitation where tap water is likely to be 
contaminated, children should only be given bottled water, 
or alternatively physically or chemically purified water, for 
drinking, rinsing their mouth or brushing their teeth. Symp-
toms of the traveller’s diarrhoea usually subside after a child 
has received an oral, or in more severe cases, intravenous 
rehydration therapy. In countries with a high prevalence 
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of infectious diseases, the use of chemotherapeutics is 
recommended as they significantly reduce the severity and 
the duration of symptoms. In children, the first-line therapy 
of the traveller’s diarrhoea is rehydration with intravenous 
fluids or oral rehydration salts and antimicrobials, such as 
azithromycin or ciprofloxacin. Azithromycin (100 mg/5 mL 
or 200 mg/5 mL oral suspension; 250 mg or 500 mg tab-
lets) is administered at a dose of 10 mg/kg bw once daily 
for 1–3 days. Ciprofloxacin (250 mg/5 mL or 500 mg/5 mL 
oral suspension; 250 mg or 500 mg tablets) is used in 
children under the age of 1 year at a dose of 10 mg/kg bw 
twice a day for 1–3 days. Antimotility drugs, e.g. loperamide, 
are not recommended in small children (contraindicated 
< 6 years) as they may cause retention of toxic substances 
in the gastrointestinal system [17–19].  
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